Dosage form: tablet
Drug class:Angiotensin receptor blockers
Medically reviewed by Drugs.com. Last updated on Mar 22, 2022.
On This Page
WARNING: FETAL TOXICITY
- When pregnancy is detected, discontinue irbesartan as soon as possible.
- Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. See WARNINGS: Fetal Toxicity.
Ibesartan Description
Irbesartan USP is an angiotensin II receptor (AT1 subtype) antagonist.
Irbesartan USP is a non-peptide compound, chemically described as a 2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one.
Its empirical formula is C 25H 28N 6O, and the structural formula:
MEDICAL DEPARTMENTS
Cardiology
Pediatrics
Diabetes Care
Pre-natal Care
Ultrasound Echocardiogram